Physicochemical Descriptors

Property Name Value
Molecular Formula C20H34AuO9PS
Molecular Weight 678.49
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Tuberculosis 2 D014376 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Pain 2 D010146 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Amebiasis 1 D000562 ClinicalTrials
Adenocarcinoma of Lung 1 D000077192 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials
Carcinoma, Squamous Cell 1 D002294 ClinicalTrials

Side Effects from Label

Side effects Relative Frequency (%) Labels
Gastrointestinal disorders Diarrhoea 47.0
Gastrointestinal disorders Diarrhoea 42.5
Skin and subcutaneous tissue disorders Dermatitis 39.0
Skin and subcutaneous tissue disorders Rash 39.0
Skin and subcutaneous tissue disorders Dermatitis 26.0
Skin and subcutaneous tissue disorders Rash 26.0
Skin and subcutaneous tissue disorders Dermatitis 24.0
Skin and subcutaneous tissue disorders Rash 24.0
Gastrointestinal disorders Stomatitis 18.0
Skin and subcutaneous tissue disorders Pruritus 17.0
Gastrointestinal disorders Abdominal pain 14.0
Gastrointestinal disorders Gastrointestinal pain 14.0
Gastrointestinal disorders Diarrhoea 13.0
Gastrointestinal disorders Stomatitis 13.0
Gastrointestinal disorders Vomiting 10.0
Renal and urinary disorders Proteinuria 5.4
Investigations Protein urine present 5.4
Renal and urinary disorders Proteinuria 5.0
Investigations Protein urine present 5.0
Blood and lymphatic system disorders Anaemia 3.1
Blood and lymphatic system disorders Anaemia 2.7
Blood and lymphatic system disorders Leukopenia 2.2
Blood and lymphatic system disorders Thrombocytopenia 2.2
Blood and lymphatic system disorders Leukopenia 1.9
Blood and lymphatic system disorders Anaemia 1.6
Blood and lymphatic system disorders Leukopenia 1.3
Renal and urinary disorders Proteinuria 0.9
Investigations Protein urine present 0.9
Blood and lymphatic system disorders Thrombocytopenia 0.9
Blood and lymphatic system disorders Agranulocytosis 0.1
Immune system disorders Angioedema 0.1
Blood and lymphatic system disorders Aplastic anaemia 0.1
Gastrointestinal disorders Colitis ulcerative 0.1
Gastrointestinal disorders Dysphagia 0.1
Renal and urinary disorders Glomerulonephritis membranous 0.1
Immune system disorders Interstitial lung disease 0.1
Blood and lymphatic system disorders Jaundice 0.1
Renal and urinary disorders Nephrotic syndrome 0.1
Nervous system disorders Neuropathy peripheral 0.1

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Immune system disorders
32.14
General disorders and administration site conditions
17.86
Skin and subcutaneous tissue disorders
14.29
Musculoskeletal and connective tissue disorders
10.71
Eye disorders
7.14
Metabolism and nutrition disorders
7.14
Surgical and medical procedures
7.14
Gastrointestinal disorders
3.57

Cross References

Resources Reference
CAS NUMBER 34031-32-8
ChEMBL CHEMBL1366
DrugBank DB00995
FDA SRS 3H04W2810V
Guide to Pharmacology 6306
PubChem 16667669